The Oncology Institute COO Jeremy Castle resigns effective May 30, 2025

Oncology Institute, Inc.

Jeremy Castle provided notice of resignation as COO, effective May 30, 2025.
Resignation not due to any disagreement with the Company on operations, policies, or practices.
No successor or interim arrangement announced.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jeremy Castle

Chief Operating Officer

TOI · Oncology Institute, Inc.

Effective: 2025-05-30
Filed: May 7, 2025, 7:59 PM ET

On May 2, 2025, Jeremy Castle provided notice of his resignation as Chief Operating Officer of The Oncology Institute, Inc. (the “Company”), effective as of May 30, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jeremy Castle resigned as Chief Operating Officer at Oncology Institute, Inc..

Action: resigned
Role: Chief Operating Officer

Exact text from the filing

On May 2, 2025, Jeremy Castle provided notice of his resignation as Chief Operating Officer of The Oncology Institute, Inc. (the “Company”), effective as of May 30, 2025.

View on SEC.gov

Oncology Institute, Inc. filing history →

Source: SEC EDGAR

accession 0001079973-25-000764

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.